ARCHIVES

Vanderbilt Wins NCI Core Grant Renewal with 12.7 Percent Funding increase

This article is from The Cancer Letter archive.

Vol. 36 No. 44 | December 3, 2010

Download PDF Visit The Full Archive

Related Articles

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

June 27, 2014

In Brief: Grace Powers Monaco Receives Lloyd Bentsen Award

July 21, 1995

IMRT Usage and Cost Related to Geography And Medicare Reimbursement Policy, Study Finds

April 29, 2011

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

March 16, 2007

NSABP Executive Committee Joins Fisher In Suit Against Pitt

August 5, 1994

Pediatric Oncology Groups Plan To Merge, Citing Greater Cost Efficiencies, Leverage

August 7, 1998